oleanolic acid 3-acetate has been researched along with osimertinib in 1 studies
| Studies (oleanolic acid 3-acetate) | Trials (oleanolic acid 3-acetate) | Recent Studies (post-2010) (oleanolic acid 3-acetate) | Studies (osimertinib) | Trials (osimertinib) | Recent Studies (post-2010) (osimertinib) |
|---|---|---|---|---|---|
| 36 | 0 | 24 | 1,315 | 134 | 1,282 |
| Protein | Taxonomy | oleanolic acid 3-acetate (IC50) | osimertinib (IC50) |
|---|---|---|---|
| Histone deacetylase 3 | Homo sapiens (human) | 1 | |
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | 3.98 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 0.1858 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 0.0274 | |
| Insulin receptor | Homo sapiens (human) | 0.912 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.26 | |
| Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (human) | 0.0268 | |
| von Hippel-Lindau disease tumor suppressor | Homo sapiens (human) | 0.002 | |
| Histone deacetylase 4 | Homo sapiens (human) | 1 | |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 0.0395 | |
| Epidermal growth factor receptor | Mus musculus (house mouse) | 0.081 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.57 | |
| Histone deacetylase 1 | Homo sapiens (human) | 1 | |
| Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | 0.033 | |
| Histone deacetylase 7 | Homo sapiens (human) | 1 | |
| Histone deacetylase 2 | Homo sapiens (human) | 1 | |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | 1 | |
| Histone deacetylase 11 | Homo sapiens (human) | 1 | |
| Histone deacetylase 8 | Homo sapiens (human) | 1 | |
| Histone deacetylase 6 | Homo sapiens (human) | 1 | |
| Histone deacetylase 9 | Homo sapiens (human) | 1 | |
| ALK tyrosine kinase receptor | Homo sapiens (human) | 0.177 | |
| Histone deacetylase 5 | Homo sapiens (human) | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Cheng, YY; Duan, HQ; Goto, M; Huang, KY; Lee, KH; Ling, Y; Liu, YL; Morris-Natschke, SL; Tong, XH; Yang, PC; Yang, SL | 1 |
1 other study(ies) available for oleanolic acid 3-acetate and osimertinib
| Article | Year |
|---|---|
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
Topics: A549 Cells; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Design; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Mutation; Nitric Oxide; Nitric Oxide Donors; Oleanolic Acid; Protein Kinase Inhibitors | 2019 |